254439-45-7

Basic information

• Product Name: N-(3-Carboxypropionyl)-L-aspartyl-L-glutamyl-(2-methyl)-L-phenylalanyl-(3-methyl)-L-valyl-N1-[1(S)-(2-amino-2-oxoacetyl)pentyl]-L-leucinamide
• CAS NO: 254439-45-7
• Molecular Formula: C₄₂H₆₃N₇O₁₄
• Molecular Weight: 890.00891
• Mol File: 254439-45-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(3-Carboxypropionyl)-L-aspartyl-L-glutamyl-(2-methyl)-L-phenylalanyl-(3-methyl)-L-valyl-N1-[1(S)-(2-amino-2-oxoacetyl)pentyl]-L-leucinamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3-Carboxypropionyl)-L-aspartyl-L-glutamyl-(2-methyl)-L-phenylalanyl-(3-methyl)-L-valyl-N1-[1(S)-(2-amino-2-oxoacetyl)pentyl]-L-leucinamide(254439-45-7)
• EPA Substance Registry System: N-(3-Carboxypropionyl)-L-aspartyl-L-glutamyl-(2-methyl)-L-phenylalanyl-(3-methyl)-L-valyl-N1-[1(S)-(2-amino-2-oxoacetyl)pentyl]-L-leucinamide(254439-45-7)

Safety Data

• Hazardous Substances Data: 254439-45-7(Hazardous Substances Data)

Relevant articles and documents

ALPHA-KETOAMIDE DERIVATIVES

The invention relates to α-ketoamides of the general formula wherein R 1to R 12have the significances given in the description, and their salts. The α-ketoamide derivatives provided by the present invention inhibit proteinases of viral origin, such as HCV protease, and can be used in the treatment of viral infections, especially viral infections caused by hepatitis C, hepatitis G and human GB viruses.